Stan Rose

Who is Stan Rose?

Stan Rose is a Ph.D. biologist, seasoned biotechnology executive, and serial entrepreneur. Dr. Rose has spent over two decades working with leading scientists and clinicians to create substantial commercial value from inventions based on genome technology.

He is President of Rose Ventures, Inc., a firm that provides consulting and directing to select clients in the life science research products space, and manages a portfolio of public and private equity investments. Dr. Rose is Executive Director of Nabsys, a life sciences company pioneering development of semiconductor-based tools for genome analysis. He is a Director of Cellular Dynamics International, the world's largest producer of fully functional human cells derived from induced pluripotent stem cells. He is a Director of Invenra, an early stage company developing novel technology for peptide drug discovery. Dr. Rose is co-founder, Director and CEO of Transplant Genomics, a molecular diagnostic services company commercializing tests to better manage organ transplant patient care and improve outcomes. He serves as Chief Business Advisor for SERUMdpt Bioscience, an early stage company developing the first device enabling real-time isolation of plasma/serum from drawn blood without centrifuging. Dr. Rose is Chair of the Market Advisory Board of Cyvek, a biotech company developing a novel multi-analyte immunoassay technology platform. Dr. Rose is a Member of Tactics II SC Management LLC, an investment fund focused on companies in the stem cell space.